.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Julphar
Cipla
Fish and Richardson
Cerilliant
Moodys
US Department of Justice
Healthtrust
Dow
Chubb

Generated: June 27, 2017

DrugPatentWatch Database Preview

Erythromycin stearate - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin stearate and what is the scope of erythromycin stearate patent protection?

Erythromycin stearate
is the generic ingredient in eight branded drugs marketed by Bristol, Mylan, Bristol Myers Squibb, Watson Labs, Warner Chilcott, Parke Davis, Purepac Pharm, Arbor Pharms Llc, Ani Pharms Inc, Wyeth Ayerst, Lederle, and Pfizer, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ninety-eight drug master file entries for erythromycin stearate. Five suppliers are listed for this compound.

Summary for Generic Name: erythromycin stearate

Tradenames:8
Patents:1
Applicants:12
NDAs:15
Drug Master File Entries: see list98
Suppliers / Packagers: see list5
Bulk Api Vendors: see list83
Clinical Trials: see list112
Patent Applications: see list9,377
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:erythromycin stearate at DailyMed

Pharmacology for Ingredient: erythromycin stearate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
ERYTHROMYCIN STEARATE
erythromycin stearate
TABLET;ORAL061505-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
PFIZER-E
erythromycin stearate
TABLET;ORAL061791-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Arbor Pharms Llc
ERYTHROCIN STEARATE
erythromycin stearate
TABLET;ORAL060359-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
ETHRIL 500
erythromycin stearate
TABLET;ORAL061605-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Warner Chilcott
ERYPAR
erythromycin stearate
TABLET;ORAL062322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Novartis
US Army
UBS
Dow
US Department of Justice
Healthtrust
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot